Announced Mon, 29 Jun · 16:47 IST
Trading window closure for Q1 FY27 results
Compliance View source PDF
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.6%1-day move
₹166.50
prior close
₹167.48
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.3-0.2-0.3+1.6+1.4+5.5+7.0+5.1+3.4+11.3———
Up moveDown movePending
AI summary
Piramal Pharma has closed its trading window for designated persons starting July 1, 2026 until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2026. This is a routine compliance measure under SEBI Insider Trading Regulations. The board meeting date to approve these Q1 results will be announced later.
Likely market impact
Routine compliance; hints at upcoming Q1 FY27 earnings. No direct impact on retail shareholders, but insiders cannot trade until after results.